Kangstem Biotech Co (XKRX:217730) Ending Cash Position : ₩2,166 Mil (As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Kangstem Biotech Co Ending Cash Position?

Kangstem Biotech Co's Ending Cash Position for the quarter that ended in Mar. 2025 was ₩2,166 Mil.

Kangstem Biotech Co's quarterly Ending Cash Position increased from Sep. 2024 (₩1,316 Mil) to Dec. 2024 (₩1,451 Mil) and increased from Dec. 2024 (₩1,451 Mil) to Mar. 2025 (₩2,166 Mil).

Kangstem Biotech Co's annual Ending Cash Position increased from Dec. 2022 (₩4,681 Mil) to Dec. 2023 (₩5,856 Mil) but then declined from Dec. 2023 (₩5,856 Mil) to Dec. 2024 (₩2,767 Mil).

Kangstem Biotech Co Ending Cash Position Historical Data

The historical data trend for Kangstem Biotech Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kangstem Biotech Co Ending Cash Position Chart

Kangstem Biotech Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

9,968.67

7,541.59

4,680.56

5,855.67

2,766.68

Kangstem Biotech Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Ending Cash Position	Get a 7-Day Free Trial															2,064.58	3,750.71	1,316.15	1,450.53	2,165.83

Kangstem Biotech Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Kangstem Biotech Co's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	5855.668	+	-3088.984
	=	2,767

Kangstem Biotech Co's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2766.684	+	-600.853
	=	2,166

Kangstem Biotech Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Kangstem Biotech Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Kangstem Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kangstem Biotech Co Ltd (XKRX:217730) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

512 Teheran-ro, Gangnam-gu, 17th Floor, Sinan Building, Seoul, KOR

Website

http://www.kangstem.com

Kangstem Biotech Co Ltd develops technology to isolate the non-hematological system stem cell with conversion and purity from the cord blood and to culture large quantity. Its Furestem therapies include Furestem-AD, Furestem-RA and Furestem-CD. Its businesses include cord blood-derived stem cell therapy business; cord blood-derived stem cell conditioned media business; and stem cell culture media business.

Kangstem Biotech Co Headlines

No Headlines